4Accepted Sep 11, 2:57 PM ET
Verizon (VZ) EVP Kyle Malady Receives Phantom Stock Award
Accepted (ET)
2:57 PM
Sep 11, 2026
Filed
Sep 11, 2026
Documents
1
Size
6.0 KB
Summary
Verizon (VZ) EVP Kyle Malady Receives Phantom Stock Award
What Happened
- Kyle Malady, Executive Vice President and Group CEO — VZ Business at Verizon Communications (VZ), was granted 121.911 phantom shares (derivative award) on 2026-09-10. The award is recorded at $14.26 per share, totaling roughly $1,738. This was an award/award acquisition (code A), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-09-10; filing date: 2026-09-11 (filed timely).
- Quantity and price: 121.911 phantom shares at $14.26 each; total value ≈ $1,738.
- Shares owned after transaction: not specified in the provided filing details.
- Footnotes: F1 — each phantom share is cash-settled and payable under a deferred compensation plan; F2 — amount includes phantom stock acquired via dividend reinvestment.
- Transaction type: Award of derivative (phantom) shares — code A.
Context
- This was a compensation award (phantom stock that is settled in cash per the plan), which is generally a routine pay-related grant rather than a direct bullish purchase of company stock. For retail investors, awards signal executive compensation alignment but do not necessarily indicate immediate buying or selling of common shares.